Perform Another (Advanced) Search

1.  Study Posting (5303) Trial #163176, Pain, New York, NY
...Study of Subcutaneous Injections of Botulinum Toxin Type A (BOTOX®) for the Treatment of Paroxysmal Trigeminal Neuralgia Botulinum Toxin Type A (BoNT-A) is a non-invasive therapy that has been demonstrated ...
View Page

2.  Newly Approved Drug Therapies (338) Carbatrol, Elan Pharmaceuticals,
...Drug Name: Carbatrol Company: Elan Pharmaceuticals Approval Status: Approved September 1997 Treatment Area: anticonvulsant and trigeminal neuralgia General Information Carbatrol by Elan Corp. has been approved as a treatment for epileptic seizures ...
View Page

3.  CenterWatch Clinical Research Profile (3) Trial #33, Palm Beach Research Center, West Palm Beach, FL
...cellulitis, osteoarthritis • Neurology: Amyotrophic lateral sclerosis (Lou Gehrig's Disease), Alzheimer's Disease, aneurysm, epilepsy (Trigeminal Neuralgia, Atypical, Glassopharyngeal and Postherpetic Neuralgia), facial pain, headaches (Tension, Depression, Cluster, Posttraumatic, Cough, and Migraines ...
View Page

4.  CenterWatch Clinical Research Profile (5303) Trial #2176, NYU Bluestone Center for Clinical Research, New York, NY
...Study of Subcutaneous Injections of Botulinum Toxin Type A (BOTOX®) for the Treatment of Paroxysmal Trigeminal Neuralgia profileinquiry@centerwatch.com bluestone.center@nyu.edu 2176 If you are interested in contacting this ...
View Page

5.  CenterWatch: Neurology Approved Drug Therapies
...Management of acute pain, Approved July 1997 Carbatrol ; Elan Pharmaceuticals; Treatment for epileptic seizures and trigeminal neuralgia, Approved September 1997 Copaxone ; Teva Pharmaceutical; Treatment for relapsing-remitting multiple sclerosis, Approved January 1997 ...
View Page

6.  CenterWatch: Clinical Trials in Category (834) Pain
...Study of Subcutaneous Injections of Botulinum Toxin Type A (BOTOX®) for the Treatment of Paroxysmal Trigeminal Neuralgia North Carolina Durham : Research Site: A Study to Assess the Efficacy of Intravenous/Oral Bondronat ...
View Page

7.  CenterWatch: List of Newly Approved Drug Thearapies
...Management of acute pain, Approved July 1997 Carbatrol ; Elan Pharmaceuticals; Treatment for epileptic seizures and trigeminal neuralgia, Approved September 1997 Copaxone ; Teva Pharmaceutical; Treatment for relapsing-remitting multiple sclerosis, Approved January 1997 ...
View Page